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Abstract
Postoperative cognitive dysfunction (POCD) is a common complication after surgery,
especially for elderly patients. Administration of RNase has been reported to exhibit neuro-
protective effects in acute stroke. However, the potential role of RNase on POCD is
unknown. Therefore, we sought to investigate whether RNase treatment could mitigate
unilateral nephrectomy induced-cognitive deficit in aged mice. In the present study, twelve-
month-old mice were administered RNase or an equal amount of normal saline periopera-
tively. All mice underwent Morris Water Maze (MWM) training 3 times per day for 7 days to
acclimatize them to the water maze before surgical operation, and testing on days 1, 3 and
7 after surgery. We found that perioperative administration of RNase: 1) attenuated unilat-
eral nephrectomy-induced cognitive impairment at day 3 after surgery; 2) reduced the hip-
pocampal cytokines mRNA production and serum cytokines protein production at day 1 and
day 7 (for MCP-1) after surgery, and; 3) inhibited hippocampal apoptosis as indicated by
cleaved caspase-3 western blot and TUNEL staining at day 1 after surgery. In addition, a
trend decrease of total serum RNA levels was detected in the RNase treated group after
surgery compared with the untreated group. Further, our protocol of RNase administration
had no impact on the arterial blood gas analysis right after surgery, kidney function and mor-
tality rate at the observed days postoperatively. In conclusion, perioperative RNase treat-
ment attenuated unilateral nephrectomy-induced cognitive impairment in aged mice.
Introduction
Postoperative cognitive dysfunction (POCD) is a common complication after surgery, espe-
cially in elderly patients [1, 2]. It is known that POCDmay occur in the acute and/or late stage
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following either cardiac or non-cardiac surgery, which is associated with poor health outcomes
of the patients [3, 4]. The reported incidence of early POCD varies in different studies, with the
highest around 80% in the first postoperative week [5], and lowest about 17% at one month
after surgery [6]. Despite years of considerable progress towards understanding the molecular
mechanisms involved in the development of POCD, the pathogenesis of POCD remains rela-
tively unclear.
Increased studies have suggested that neuroinflammation may play a central role in the
pathogenesis of POCD [7, 8]. However, clinical trials using anti-inflammatory drugs, such as
non-steroidal anti-inflammatory drugs (NSAIDs), have failed to show either consistent benefi-
cial effects in patients with mild cognitive impairment or usefulness in the treatment of estab-
lished dementia [9]. There is growing evidence that systemic inflammation can induce
exacerbation and progression of inflammatory responses or damage in the central nervous sys-
tem (CNS) [10, 11]. Therefore, we reasoned that it might be of great importance to identify the
inflammatory initiators that are involved in the mediation, amplification and perpetuation of
postoperative neuroinflammatory reactions. Additionally, damping the systemic initiators at
early stages may help to prevent the chain reaction that triggers the inflammatory or apoptotic
response in the CNS.
Damage-associated molecular pattern molecules (DAMPs) are molecules might be gener-
ated and released during adverse conditions, such as tissue trauma, ischemia, and hypoxia [12].
DAMPs can trigger responses of immune system in the noninfectious inflammatory response.
DAMPs encompass various types of molecules, (e.g., heat-shock proteins, high mobility group
box 1 (HMGB1), RNA, and S100 proteins) [13]. Recent studies have demonstrated that
HMGB1 and S-100βmay be associated with POCD [14, 15]. Extracellular RNA (exRNA),
released from necrotic cells, has been recently reported to be involved in pathological condi-
tions such as myocardial ischemia/reperfusion (I/R) injury [16], atherosclerotic plaque forma-
tion [17], and focal cerebral ischemia [18]. Besides its role as the information bridge between
DNA and protein, exposure of various cells to exRNA also can result in inflammatory
responses through upregulation of the pro-inflammatory mediators [16]. Previous studies have
shown that administration of Ribonuclease (RNase), the counterpart of exRNA, significantly
reduced myocardial infarction in the mouse model of myocardial I/R injury. It is suggested
that reduction of inflammation and apoptosis could be the possible molecular mechanism for
the protective effects of RNase [16]. Notably, RNase has also been proven to be neuroprotective
in a rat model of temporary middle cerebral artery occlusion, through reduction of leakiness of
the blood brain barrier or brain edema formation [19]. Therefore, it is of great interest to test
whether RNase treatment may play a role in POCD.
Therefore, in this study, we aimed to evaluate if RNase treatment may confer neuroprotec-
tion from POCD in a surgical model of aged mice. We also evaluated kidney function, per-
formed arterial blood gas analysis after RNase administration, and further determined the
possible mediators and the molecular mechanisms that may be associated with initiation and
development of cognitive impairment.
Materials and Methods
Animals and Experimental Procedures
C57BL/6 male mice, aged 12 months, weighing 26–35g, were purchased from Sichuan Univer-
sity, P.R.China and maintained under controlled conditions on a 12 h light/dark cycle with free
access to laboratory food and water. The study was approved by the Animal Care and Use
Committee of Sichuan University (Permit Number: 20111020002), and conformed to the
Guide for the Care and Use of Laboratory Animals published by the US National Institutes of
RNase Treatment and POCD
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Health (NIH Publication No. 85–23, revised 1996). All surgery was performed under the com-
bination of ketamine and xylazine anesthesia, and all efforts were made to minimize suffering.
Aged mice were randomly assigned to 3 groups: sham surgery plus placebo (S-S), surgery plus
placebo (S-P), and surgery plus RNase (S-R). Briefly, mice were anesthetized by intraperitoneal
injection of ketamine (120 mg/kg) and xylazine (4 mg/kg), a small transverse incision was
made and the left kidney was removed (S-P and S-R groups), or only exposure of kidney was
made without excision (S-S group). The S-R group received 3 doses of RNase A before, during
and after the surgery respectively. The S-S and S-P groups only received normal saline of equal
volume at corresponding time points. During the operation, body temperature of the mice was
maintained at 36.5°C to 37.5°C. All the mice received 50μl of 0.2% ropivacaine subcutaneously
for the post-operative analgesia.
Morris Water Maze Test
Morris Water Maze (MWM) was chosen for the assessment of learning and memory, one
aspect of the cognition [20]. Briefly, the water maze consisted of a round tank (diameter: 120
cm, depth: 40 cm) of water rendered opaque by adding white non-toxic paint, and the water
temperature was maintained at 25°C. A platform submersed 1 cm below surface was placed in
one quadrant of the tank and maintained in the same position during all trials. Several visual
clues were placed around the pool as the mice’s navigational reference points for locating the
platform. A video camera in conjunction with the SMART video tracking software (Panlab,
Barcelona, Spain) was used for the measurement of swimming speed, latency to escape to the
platform, percentage of time spent in the target quadrant and distance swam to the platform.
The training session consisted of 3 consecutive trials per day for 7 days before surgery (Fig
1A), during which the mice were placed in the desired start position in the maze facing the
tank wall, and allowed to swim freely to the escape platform. Trial time limit is 90 seconds. If
the mice did not find the platform within the time limit, they were gently guided to it. The test-
ing session including 3 consecutive trials was performed for 7 days after surgery (Fig 1A). The
probe tests with the platform removed were performed on the 3rd or 7th postoperative day.
The probe test was 90 seconds in duration, and the percentage of time spent in the quadrant
previously containing the submerged platform was recorded.
In vivo RNase Administration
RNase A (Invitrogen), a bovine pancreatic ribonuclease with high efficiency for the degrada-
tion single-stranded RNA, was used in this study after filtration (30 kDa cut-off filter). Briefly,
3 doses of RNase A were administered as follows: 500 μg/100 μl, SC, 30 minutes prior to,
200 μg/200 μl, IP, right before, and 500 μg/100 μl, SC, 1 hour after unilateral nephrectomy
(Fig 1B), which has been reported previously [16].
Arterial Blood Gas Analysis
Immediately after the surgery, whole blood samples were taken with a heparin coated syringe
from the left ventricles of mice from all the four groups (S-S, S-P, S-R, and naïve group, n = 3
per group) for arterial blood gas analysis. Blood gas analyzer (ABL800 FLEX, Radiometer Med-
ical A/S, Copenhagen, Denmark) was used for the measurement of pH, blood gas (pCO2,
pO2), electrolytes (cCl-, cCa++, cK+, cNa+), metabolites (cLac) and oximetry: ctHb, sO2.
RNase Treatment and POCD
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Serum Preparation
Mouse whole blood was collected in the RNase-free Eppendorf tubes at four time points: base-
line, day 1, day 3 and day 7, after the cognitive tests. After collection of the whole blood, it was
left undisturbed at room temperature for about 30 minutes, followed by centrifugation at
3,000 x g for 10 minutes at 4°C. The supernatant serum was collected. These experiments were
performed in the strictly RNase-free conditions.
Kidney Function Test
An automatic chemistry analyzer (BS-120 Chemistry Analyzer, Mindray) was used for the
measurement of creatinine (CREA) and blood urea nitrogen (BUN), in the serum collected at
the corresponding time points. Three mice aged 12 months maintained under the same con-
trolled conditions as that of all the other 3 groups (S-S, S-P, and S-R) were used as the naïve
control.
Quantification of Total Serum RNA Concentration and Cytokines mRNA
Equal volume (100 μl) of serum from all the groups were used for the abstraction and quantifi-
cation of total serum RNA. DNA-free total serum RNA was extracted by using Eastep
Universal RNA Extraction Kit and quantified using Thermo Scientific NanoDrop 2000 spec-
trophotometer. These experiments were also conducted in strictly RNase-free conditions. Total
RNA from hippocampus tissues was isolated using TRIzol reagent (Invitrogen Life Technolo-
gies). qRT-PCR was performed on a Mastercycler ep realplex realtime PCR system (Eppendorf,
Hauppauge, NY). The level of GAPDH was used to normalize data in each individual sample.
The primer sequence used for qRT-PCR were described previously [16].
Quantification of Serum Cytokines Protein
Luminex multiplex fluorescent bead-based immunoassays (Milliplex MAPMouse cytokine
kit) were used to simultaneously detect multiple cytokine expression in the serum based on the
Fig 1. The schematic outline of the experimental protocol and the timeline of RNase administration. A,
Schematic outline of the experimental protocol. B, Timeline of RNase A administration. MWM, Morris water
maze; S-S, sham surgery plus placebo; S-P, surgery plus placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.g001
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manufacturer’s protocol. A set of selective cytokines was included in the Luminex assay to mea-
sure the cytokine protein expression levels in the serum samples.
Western Blot Analysis
Total protein was extracted as described [21]. Equivalent amounts of proteins (100 μg) were
separated by 10% or 15% SDS-PAGE and transferred onto a polyvinylidene fluoride (PVDF)
membrane (Millipore). The membranes were sequentially incubated with anti-cleaved caspase-
3 antibody (1:1000, Cell Signaling Technology, USA) overnight and anti-GAPDH antibody
(1:2000, Cell Signaling Technology, USA) for 4 hours at 4°C. Immunoreactivity was detected
with ECL fluorescent detection reagent, and analyzed by NIH Image J software. β-Actin was
used as a loading control.
TUNEL Staining
For detection of apoptosis in paraffin-embedded tissue, terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) staining was performed using an In Situ Cell Death Detec-
tion Kit (POD; Roche Diagnostics Corp., Indianapolis, IN, USA) following the protocol
reported previously. Cells with brown nuclei were counted in 6 microscopic fields of the CA1
region (400 x) from each section of the hippocampus, and the percentage of TUNEL-positive
nuclei was calculated.
Statistical Analysis
All data were expressed as means ± SEM. The statistical analysis was performed using Graph-
pad Prism 6 software. Analysis of data was performed using one-way analysis of variance
(ANOVA). Post hoc analysis (Student-Newman Keul’s test) was performed for multiple
comparisons between different groups of these experiments. Probability values less than
0.05 (P<0.05) were considered statistically significant.
Results
RNase Treatment Attenuated Unilateral Nephrectomy-Induced
Cognitive Dysfunction
Assessment of hippocampal-dependent learning and memory by MWM in all treatment
groups at day 3 postoperatively demonstrated a statistically significant reduction in memory
retrieval in S-P group compared to the S-S group, as evidenced by escape latency, path
length, and percentage of time spent in target quadrant respectively (Fig 2A–2C), suggesting
that unilateral nephrectomy induced a significant cognitive impairment in aged mice, therefore
emulating POCD. The S-P group had similar swimming speed as that of the S-S group
either pre or postoperatively (Fig 2D), implying that surgical operation per se had no impact
on exercise capacity of the mice. Importantly, RNase treatment led to significantly enhanced
cognitive function, compared with untreated surgical group, as demonstrated by escape latency
(23.01 ± 5.15 vs. 43.67 ± 7.23, #P< 0.05) (Fig 2A), path length (333.20 ± 60.60 vs. 636.33 ±
89.72, #P<0.05) (Fig 2B), and percentage time spent in target quadrant (27.08 ± 2.84% vs.
24.21 ± 1.33%, #P<0.05) (Fig 2C), indicating that RNase treatment can attenuate POCD
induced by unilateral nephrectomy in aged mice. Likewise, there was no difference in swim-
ming speed either pre or postoperatively between S-R group and S-P group (Fig 2D). Addition-
ally, a probe test was conducted at day 3 and day 7 after surgery to test whether the mice had
learned and could recall the spatial location of the hidden platform. The percentage of time
spent in the quadrant with the previously located hidden platform was significantly less in the
RNase Treatment and POCD
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S-P group undergoing probe tests (29.00 ± 1.88% and 36.12 ± 0.80%) when compared with the
S-S group (39.48 ± 3.06% and 42.00 ± 2.11%) on day 3 and day 7 after surgery, respectively
(Fig 2E, P<0.05). The S-R group undergoing probe tests had a significantly higher percentage
of time spent in the target quadrant compared to that of the S-P group at day 3 after surgery
(37.66 ± 2.28% vs. 29.00 ± 1.88%, #P< 0.05) (Fig 2E). Additionally, RNase treatment had no
impact on the sham group (data not shown). Taken together, the above results revealed that
unilateral nephrectomy induced a significant cognitive impairment, which could be attenuated
by perioperative RNase treatment.
Effects of RNase Treatment on Physiologic Parameters and Mortality
The comparison of the arterial blood gas parameters among groups (S-S, S-P, S-R and naive)
is summarized in Table 1. Physiologic parameters, such as pH, blood gas (pCO2, pO2),
electrolytes (cCl-, cCa++, cK+, cNa+), metabolites (cLac) and oximetry (ctHb, sO2), had no
significant difference among groups (S-S, S-P, and S-R) immediately following surgery
when compared with that in the naive controls (Table 1). Also, mice undergoing RNase treat-
ment all survived on the observation days after surgery. Only one mouse from the S-S group in
the experiment of MWM testing died at day 1 after surgery (data not shown). These results
Fig 2. RNase treatment reduced cognitive impairment induced by unilateral nephrectomy surgery in
agedmice. The MWMwas used for the training of spatial memory formation in aged mice for 7 days before
experiments and followed by the postoperative testing of reversal learning for 7 days. A, Escape latency
during the experiments. B, Percentage of time spent in the target quadrant during the experiments. C,
Swimming path length during the experiments. D, Swimming speed during the experiments. E, The probe trial
test at day 3 and day 7 after surgery. F, Representative swim paths for S-R and S-P group at day 3 after
surgery. The above data are shown as mean ± SEM; n = 10 for training; n = 8 for testing. *P<0.05 v.s. S-S
group, #P<0.05 v.s. S-R group. S-S, sham surgery plus placebo; S-P, surgery plus placebo; S-R, surgery
plus RNase.
doi:10.1371/journal.pone.0134307.g002
RNase Treatment and POCD
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indicate that perioperative RNase treatment used in our study did not have any impact on the
physiology parameters and mortality.
Effect of RNase Treatment on DNA-Free Total Serum RNA
As one of the important DAMPs, exRNA, such as ribosomal RNA, transfer RNA, and messen-
ger RNA, may be released from damaged cells during surgical injury. Therefore, we measured
the total serum RNA levels at day 1, day 3 and day 7 after surgery in the S-S, S-P, and S-R
group, in order to evaluate the functional role of exRNA in nephrectomy induced cognitive
dysfunction. We have found total serum RNA was significantly increased in the S-P group
compared with that of the S-S group at day 1 (3.40± 0.49 v.s. 2.41 ± 0.08, P<0.05, n = 5) and
day 3 (3.00 ± 0.16 v.s. 2.38 ± 0.09, P<0.05, n = 5) after surgery, whereas there was no differ-
ence between S-S group and Naïve group (n = 6 for naïve group) (Fig 3). Notably, total serum
RNA level had a decreasing trend in the S-R group at day 3 (P = 0.15) and day 7 (P = 0.09)
postoperatively (n = 5) (Fig 3). This suggests that perioperative administration of RNase, the
counterpart of exRNA, may reduce the serum levels of RNA. Taken together, these data suggest









7.38±0.04 43.83±2.17 94.97±1.17 10.97±1.95 90.63±5.00 5.30±0.10 155.67±3.48 1.24±0.13 122.00±0.58 1.77±0.48
S-S group 7.36±0.03 44.13±2.64 100.17±7.49 11.67±0.34 88.00±1.17 5.30±0.17 162.00±4.62 1.14±0.03 124.33±1.76 1.73±0.12
S-P group 7.36±0.01 46.43±1.68 99.80±5.69 13.97±0.72 86.70±2.20 5.43±0.24 152.33±3.84 1.16±0.05 121.67±0.67 1.03±0.19
S-R group 7.36±0.02 45.30±1.29 93.57±1.17 11.17±0.62 88.07±0.70 5.57±0.13 156.33±1.86 1.17±0.05 123.00±0.58 1.83±0.18
Data are shown as mean ± SEM (n = 3). There are no statistically signiﬁcant differences for all the physiology parameters among the four groups. S-S,
sham surgery plus placebo; S-P, surgery plus placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.t001
Fig 3. Effect of RNase administration on total serumRNA after unilateral nephrectomy in agedmice.
The concentration of total serum RNA at day 1, day 3 and day 7 after surgery in aged mice from all three
groups and the naïve control group were measured. Data are presented as mean ± SEM (n = 5 per group;
n = 6 for naïve control group). *P<0.05 vs. S-S group. S-S, sham surgery plus placebo; S-P, surgery plus
placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.g003
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that the protective effect of RNase treatment on the unilateral nephrectomy-induced cognitive
dysfunction might be associated with the reduction of exRNA released after surgical injury.
RNase Decreased Cytokines Expression in the Serum and
Hippocampus after Unilateral Nephrectomy
Unilateral nephrectomy dramatically increased mRNA expression of CXCL1 and MIP-2 in
the hippocampus at day 1 in aged mice compared with the sham control. This increase was sig-
nificantly reduced by perioperative treatment with 3 doses of RNase (Fig 4A, P<0.001,
P<0.0001). For MCP-1 the increase in the S-P group reached significance at day 7 after
surgery and was also attenuated by RNase treatment (Fig 4A, P<0.05, P<0.01). Serum cyto-
kines protein expression including IL-1β, IL-6, KC, and TNFα were significantly increased in
the S-P group compared with the sham control at day 1 after surgery, and the increase was also
significantly decreased in the S-R group (Fig 4B, P<0.05). There was no difference between
the S-R group and the S-S group. These results indicate that neuroprotective effect of RNase
may be mediated through reducing both peripheral and hippocampus inflammation.
RNase Attenuated Unilateral Nephrectomy-induced Apoptosis in the
Hippocampus
The percentage of TUNEL-positive nuclei in the total nuclei of the hippocampal CA1 region
was markedly increased in the S-P group, compared with the S-S group at day 1 after surgery.
The increase was significantly inhibited by administration of RNase (Fig 5A and 5B, P<0.05,
P<0.01). Protein expression of cleaved caspase 3 in the hippocampus was significantly
increased at day 1 in the S-P group compared with the sham control, and RNase treatment sig-
nificantly reduced this increase (Fig 5C, P<0.05). There was no difference between the S-S
group and the S-R group. Besides, for both TUNEL staining and cleaved caspase 3, no
Fig 4. RNase treatment decreased cytokine expression in the hippocampus and serum after unilateral
nephrectomy in agedmice. A, Hippocampal cytokine mRNA. At day 1, day 3 and day 7 after surgery,
cytokine mRNA levels were measured using qRT-PCR. B, Serum cytokine protein expression. At day 1, day
3 and day 7 after surgery, cytokine proteins were assayed using Luminex. Data are presented as
mean ± SEM (panel A, n = 4 per group; panel B, n = 6 per group). *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001. CXCL1, chemokine (C-X-C mortif) ligand 1; MIP-2, macrophage inflammatory protein-2;
MCP-1, monocyte chemotactic protein-1; IL, interleukin; TNF, tumor necrosis factor; S-S, sham surgery plus
placebo; S-P, surgery plus placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.g004
RNase Treatment and POCD
PLOSONE | DOI:10.1371/journal.pone.0134307 July 30, 2015 8 / 13
differences were observed among the three groups (data not shown). The above data suggest
that attenuation of hippocampal apoptosis in the early stage after surgery may also be involved
in the neuroprotection provided by RNase treatment.
Kidney Function after Experiments
In terms of the postoperative kidney function, reflected by the serum levels of CREA and BUN,
there were no significant changes among groups (S-S, S-P, S-R) at day 1, day 3 and day 7, when
compared to the naive controls (Table 2).
Discussion
In the present study, the effect of RNase treatment on cognitive function after unilateral
nephrectomy was investigated in aged mice. Our data revealed that unilateral nephrectomy
induced a significant cognitive impairment in aged mice at day 3 after surgery, while
Fig 5. RNase treatment attenuated hippocampal apoptosis after unilateral nephrectomy in agedmice.
A, TUNEL staining at day 1 after surgery. A-a, S-S group; A-b, S-P group; A-c, S-R group. B, Quantitation of
TUNEL staining. C, Quantitation of relative intensity of cleaved caspase-3 bands and a representative blot at
day 1 after surgery. Data are presented as mean ± SEM (panel B, n = 6 per group; panel C, n = 3 per group).
*P<0.05, **P<0.01. S-S, sham surgery plus placebo; S-P, surgery plus placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.g005
Table 2. Kidney function after experiments.
CREA(μmol/L) BUN(mmol/L)
Naïve group 38.78±1.03 7.26±0.37
S-S group Day 1 39.57±0.41 10.76±1.40
Day 3 39.60±0.81 9.52±0.29
Day 7 36.07±1.52 7.49±0.53
S-P group Day 1 43.97±1.68 16.30±1.61
Day 3 41.07±3.03 10.85±0.72
Day 7 38.87±0.35 9.45±0.76
S-R group Day 1 45.77±2.31 13.70±2.84
Day 3 34.90±0.51 6.18±0.43
Day 7 37.97±1.27 8.57±0.67
Data are shown as mean ± SEM (n = 3). There are no statistically signiﬁcant differences among groups
(S-S, S-P, and S-R) at day 1, day 3 and day 7 after surgery for both CREA and BUN when compared with
the naïve control group. CREA, creatinine; BUN, blood urea nitrogen; S-S, sham surgery plus placebo;
S-P, surgery plus placebo; S-R, surgery plus RNase.
doi:10.1371/journal.pone.0134307.t002
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perioperative administration of RNase led to improved cognitive function at the corresponding
time point. Moreover, RNase treatment decreased cytokine expression levels in the serum and
hippocampus, and also inhibited hippocampal apoptosis induced by unilateral nephrectomy.
In addition, significantly increased total serum RNA levels were detected in the surgery group
compared with the sham control. However, there was a decreasing trend of total serum RNA
levels in the RNase treated group at both day 3 and day 7, which implies a potential association
between the increased exRNA and the initiation of POCD. Also, the protocol of RNase admin-
istration had no impact on the arterial blood gas parameters immediately following surgery,
kidney function, and mortality rate at the observed days after surgical procedure.
Despite years of effort to find a possible treatment for patients with POCD, researchers still
fail to fully understand the pathophysiology for the development of POCD [22]. Previously,
various types of surgery, such as partial hepatolobectomy [23], splenectomy [14], and unilateral
nephrectomy [24], have been reported for the establishment of an animal model for POCD.
Increased neuroinflammation has been demonstrated to be the key mechanism for the devel-
opment of POCD in animal models [7, 8]. However, clinical trials using anti-inflammatory
drugs fail to show consistent benefits for patients with cognitive dysfunction [9]. Thus, we
aimed to find a possible treatment that could work on the initiators at the very beginning stage
involved in the initiation, amplification and perpetuation of neural inflammation or apoptosis.
Previous studies have shown increased concentration of protein levels of systemic S-100β and
HMGB-1, and their pivotal role in surgery-induced cognitive deficits [14, 15]. It is known that,
both S-100β and HMGB-1 are the important DAMPs molecules, which might be generated
and released during adverse conditions, mediating responses of the immune system in the non-
infectious inflammatory processes [13]. As one of the important DAMPs molecules, exRNA, is
able to remain in circulation after being released from necrotic cells, because it is protected by
exsome, binding-proteins from the digestion of RNase existing within our circulatory system
[25]. Previously, released exRNA was reported to be involved in the pathogenesis of myocardial
I/R injury [16], atherosclerotic plaque formation [17], and focal cerebral ischemia [18]. In the
present study, we have also detected significantly increased total serum RNA levels at day 1,
day 3 and day 7 after unilateral nephrectomy compared with the sham control. Increased
serum levels of exRNA in the mice model of POCDmay indicate a possible association
between exRNA and the cognitive injury after surgery.
RNase, the counter part of RNA, was mostly reported as a promising novel anticancer drug
target [26]. Studies have demonstrated that brain edema and infarction induced by cerebral
ischemia reperfusion were reduced by RNase treatment [18, 19]. Also, RNase treatment led to
significantly decreased myocardial infarction induced by myocardial I/R injury [16]. However,
to the best of our knowledge, the effect of RNase treatment on the development of POCD has
not been explored. Thus, we proposed that exRNA may play in an important role in the devel-
opment of POCD, and RNase A, through digesting the exRNA, may help to improve cognitive
impairment induced by surgical injury in aged mice. In our present study, we, for the first time,
demonstrate that RNase A treatment leads to cognitive improvement after unilateral nephrec-
tomy in aged mice. The protocol of perioperative RNase A administration we used showed a
good tolerability in aged mice, as it had no impact on arterial blood gas parameters, serum lev-
els of CREA or BUN and mortality rate after the surgical procedure. However, we did not find
a significant reduction of total serum RNA levels after RNase treatment, but only found a
decreasing trend at day 1, day 3 and day 7 after surgery. The reason that we failed to obtain a
significant difference of total serum exRNA may be due to the fact that RNase A degrades
ssRNA efficiently, but not other exRNA, such as rRNA, mRNA and miRNA. Although our
data has revealed the protective effect of RNase administration against the development of
POCD, further study is required to confirm whether this protection is associated with the
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degradation of serum exRNA. Additionally, confirmation of which specific exRNA is involved
in this process would then be warranted.
Molecular mechanisms for the neuroprotection provided by RNase may be related to the
reduction of both peripheral and central inflammation, and hippocampus apoptosis. In our
study, serum protein levels of IL-1β, IL-6, CXCL-1 and TNF-α were significantly increased at
day 1 after surgery, which is similar to the findings of previous research [7]. Notably, RNase
treatment markedly suppressed the increased protein levels of these cytokines. To our surprise,
we only found RNase treatment significantly reduced the mRNA levels of chemokines, namely,
CXCL1, MIP-2 and MCP-1 in the hippocampus at day 1 or day 7 after surgery, but failed to
detect differences for IL-1β, IL-6, and TNF-α (data not shown). Also, cleaved caspase-3 and
TUNEL-positive nuclei in the hippocampal CA1 region were observed to be significantly
diminished after RNase treatment at day 1 after surgery. Similarly, a previous study by Ter-
rando et al. [7] showed an early increased level of systemic pro-inflammatory cytokines, like
TNF-α, 30 min after surgery in aged mice subjected to an open tibial fracture. Meanwhile,
Rudolph et al. [27], in a clinical study, found that increased levels of chemokine in the early
stages after surgery was associated with patients developing POCD. The reason that we only
observed the changes of chemokines, mRNA levels, and apoptosis in the hippocampus at 1 day
may be because the mice model we used was a relatively mild-to-moderate injury model. The
innate recovery process of the mice, automatically activated after the surgical injury, may lead
to the attenuation of exRNA, and therefore the later reduction of chemokine levels. Moreover,
Kong et al. [21] has also demonstrated an early increased apoptosis (4 hours after isoflurane
exposure) in the hippocampus of aged rats with cognitive decline. Although the exact mecha-
nism behind these results remains elusive, we believe that released exRNA may induce the
early-stage increased hippocampal chemokines and apoptosis by acting on the peripheral or
central DAMPs receptor. This may then trigger a cytokine and/or apoptotic cascade contribut-
ing to the development of POCD. Admittedly, our current study still cannot rule out the possi-
bility that peripheral cytokines may pass through blood brain barrier to act as the initiators of
neural injury after surgery.
Our study certainly has some limitations. We treated the mice with RNase A, one of the
pancreatic-type ribonucleases that is of high efficiency for the degradation of ssRNA substrates.
However, it remains elusive as to what the specific kind of exRNA and how complete the
digestion would be affected by the systemically administered RNase A in vivo, since certain
microvesicles or RNA-binding proteins associated RNA have been found to be protected from
digestion. Also, RNase A has a small molecular weight (17 kDa) and has been found to have a
short (about several minutes) plasma half-life, with a rapid clearance primarily via kidney [28].
It could be more effective and lasting for the digestion of exRNA if an osmotic capsule could be
used to continuously administer RNase A. Further, our results indicate a possible causal rela-
tionship between the increased serum exRNA and the initiation of POCD. Further study is
required to detect the exRNA level in the cerebral spinal fluid to further support the association
between increased exRNA and cognitive impairment. Finally, although our work has indicated
that reduction of inflammation and apoptosis might be the underlying mechanisms that are
involved in the cognitive protection effects of RNase, the detailed signaling mechanism remains
to be defined.
Conclusion
In summary, the results of our study revealed that RNase treatment may attenuate unilateral
nephrectomy-induced cognitive impairment in aged mice. Perioperative RNase administration
might cause a trending decrease of exRNA in the serum, but had no impact on physiological
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parameters and mortality. RNase treatment may exhibit cognitive protective effect by reducing
peripheral inflammation, hippocampal inflammation, and apoptosis. The current study may
help to expand the knowledge base for a novel therapy for POCD, and RNase may be a promis-
ing candidate for the improvement of cognitive function after surgery. Further studies are still
needed to fully characterize such a phenomenon and elucidate the detailed underlying
mechanisms.
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